Takeda Pharmaceutical（4502）

Issuer Code Long Term Short Term
Takeda Pharmaceutical 4502 AA-/Stable J-1+

News ReleaseMore

Apr. 22, 2025
JCR Assigned Preliminary AA- Rating to Shelf Registration of Takeda Pharmaceutical
Oct. 03, 2024
JCR Affirmed AA-/Stable and J-1+ on Takeda Pharmaceutical
Jul. 09, 2024
JCR Assigned A Rating to Subordinated Loan of Takeda Pharmaceutical
Jun. 07, 2024
JCR Assigned A Rating to Subordinated Bonds of Takeda Pharmaceutical
Apr. 15, 2024
JCR Assigned Preliminary A Rating to Subordinated Bonds of Takeda Pharmaceutical
Sep. 08, 2023
JCR Assigned Preliminary AA- Rating to Shelf Registration of Takeda Pharmaceutical
Jul. 11, 2023
JCR Affirmed AA-/Stable and J-1+ on Takeda Pharmaceutical
Dec. 15, 2022
Takeda Pharmaceutical Acquires New Drug Candidate for USD 4 Billion - Limited Impact on Rating
Oct. 03, 2022
JCR Upgraded Rating on Takeda Pharmaceutical to AA-/Stable and J-1+
Jun. 15, 2022
Highlights of Major Pharmaceutical Companies' Financial Results for Fiscal Year Ended March 2022

Issuer ReportsMore

Oct. 09, 2024

Takeda Pharmaceutical

Issuer Reports
Jul. 21, 2023

Takeda Pharmaceutical

Issuer Reports
Jun. 04, 2021

Takeda Pharmaceutical

Issuer Reports
May. 28, 2020

Takeda Pharmaceutical

Issuer Reports
Feb. 06, 2019

Takeda Pharmaceutical

Issuer Reports

ESG Credit OutlookMore

Reports relating to IssuerMore

Rating Lists
Corporates
Financial Institutions
Public Sector
Structured Finance (Investment Corporations)
Structured Finance (Structured Finance Products)
Sovereigns and Supranationals